Aesica Expands Oral Solids Capability at German Facility

Article

Aesica adds roller compaction unit for dry granulation production.

Aesica Pharmaceuticals, a CDMO, is adding additional services in its oral solids capability including a new roller compaction unit for dry granulation production in Zwickau, Germany.

The new roller compaction unit uses a continuous production step that enhances product uniformity and has been undertaken following a market demand for pharmaceutical formulation technologies that enable the formulation of APIs otherwise inhibited by the presence of water.

Source: Aesica Pharmaceuticals

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Recent Videos
Lee Cronin, founder and CEO of Chemify
Nicole Hunter, head of Global WMArchitect at Watson-Marlow Fluid Technology Solutions
Related Content
© 2025 MJH Life Sciences

All rights reserved.